| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |